Latest Advances

  • Condition: Pulmonary Metastases from Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Journal: Acta medica Okayama
  • Treatment Used: Adjuvant Chemotherapy (Cetuximab and Nivolumab)
  • Number of Patients: 45
  • Published —
This study evaluated the treatment outcomes of adjuvant chemotherapy for patients with pulmonary metastases from head and neck squamous cell carcinoma (HNSCC).
  • Condition: Head and Neck Squamous Cell Carcinoma
  • Journal: In vivo (Athens, Greece)
  • Treatment Used: Paclitaxel Combined With Cetuximab
  • Number of Patients: 38
  • Published —
In this study, researchers evaluated the safety and effectiveness of paclitaxel and cetuximab combination therapy for the treatment of squamous cell carcinoma of the head and neck.
  • Condition: Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Journal: Scientific reports
  • Treatment Used: Nivolumab
  • Number of Patients: 0
  • Published —
This study analyzed the predictive impact of C-reactive protein to albumin ratio for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) receiving nivolumab.
  • Condition: Head and Neck Squamous Cell Carcinoma
  • Journal: Medicine
  • Treatment Used: Anti-PD1/PD-L1 versus Standard of Care
  • Number of Patients: 1345
  • Published —
The study researched the outcomes of anti-PD1/PD-L1 versus standard of care for treating head and neck squamous cell carcinoma.
  • Condition: Head and Neck Squamous Cell Carcinoma
  • Journal: PloS one
  • Treatment Used: PI3k Inhibitors and Radiotherapy
  • Number of Patients: 0
  • Published —
The study researched the outcomes of PI3k inhibitors and radiotherapy in patients with head and neck squamous cell carcinoma.
  • Condition: Recurrent Head and Neck Squamous Cell Carcinomas
  • Journal: Scientific reports
  • Treatment Used: Salvage Surgery
  • Number of Patients: 164
  • Published —
This study evaluated salvage surgery in the treatment of patients with recurrence of head and neck cancer.
  • Condition: Locoregionally Advanced Head and Neck Cancer
  • Journal: Radiation oncology (London, England)
  • Treatment Used: (Chemo)radiotherapy With and Without Prophylactic Percutaneous Endoscopic Gastrostomy
  • Number of Patients: 310
  • Published —
This study analyzed treatment-related unplanned hospitalizations (TRUH) in patients with advanced head and neck squamous cell carcinoma undergoing (chemo)radiotherapy with or without prophylactic percutaneous endoscopic gastrostomy tubes.
  • Condition: Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Journal: Scientific reports
  • Treatment Used: Nivolumab
  • Number of Patients: 30
  • Published —
This study analyzed whether molecular phenotypes of circulating tumor cells (CTCs) are associated with outcomes in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
  • Condition: Squamous-Cell Carcinoma of the Head and Neck
  • Journal: European journal of cancer (Oxford, England : 1990)
  • Treatment Used: Avelumab-Cetuximab-Radiotherapy versus Standards of Care
  • Number of Patients: 82
  • Published —
The study compared the outcomes of avelumab-cetuximab-radiotherapy versus standards of care for treating squamous-cell carcinoma of the head and neck.
  • Condition: Facial Reconstructive Surgery Involving Zygoma and Orbit
  • Journal: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
  • Treatment Used: Composite Submental Flaps
  • Number of Patients: 0
  • Published —
This case series describes the use of composite submental flaps in patients undergoing facial reconstructive surgery involving the zygoma (cheekbone) and orbit (eye socket).
Showing 1-12 of 328